Why the study?
Is CT-derived abdominal fat density associated with adipokines and biomarkers of cardiometabolic risk?
Is CT-derived abdominal fat density associated with adipokines and biomarkers of cardiometabolic risk?
CT-derived abdominal fat density may serve as a valid imaging biomarker for assessing cardiometabolic risk.
Answers are grounded in this paper and cite their sources.
CT fat density may aid risk stratification on imaging; leaves open incremental value and needs prospective validation.
Lower abdominal fat density was associated with a profile of biomarkers suggestive of greater cardiometabolic risk. These observations support that fat density may be a valid biomarker of cardiometabolic risk.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: